Follow
Dr. Cevdet ZÜNGÜN
Dr. Cevdet ZÜNGÜN
Düzen Laboratories Group
Verified email at duzen.com.tr
Title
Cited by
Cited by
Year
Serum amyloid A, fetuin-A, and pentraxin-3 levels in patients with ischemic stroke: novel prognostic biomarkers?
S Sezer, F Uçar, EK Ulusoy, S Erdoğan, Ş Bilen, C Züngün, S Uysal, ...
Turkish journal of medical sciences 44 (1), 16-23, 2014
352014
Impact of 6% starch 130/0.4 and 4% gelatin infusion on kidney function in living-donor liver transplantation
A Demir, B Aydınlı, HI Toprak, Ü Karadeniz, FM Yılmaz, C Züngün, P Ucar, ...
Transplantation proceedings 47 (6), 1883-1889, 2015
222015
Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotoxıc effects of organıc solvent exposure
C Züngün, FM Yilmaz, E Tutkun, H Yilmaz, S Uysal
Clinical Toxicology 51 (8), 748-751, 2013
212013
Serum PGE2, 15d-PGJ, PPARγ and CRP levels in patients with schizophrenia
RN Yüksel, AP Titiz, ET Yaylacı, K Ünal, T Turhan, G Erzin, C Züngün, ...
Asian journal of psychiatry 46, 24-28, 2019
162019
Association between some inflammatory markers and primary ovarian insufficiency
G Yldrm, A Tokmak, MK Kokanal, E Sarkaya, C Züngün, HA Inal, ...
Menopause 22 (9), 1000-1005, 2015
162015
Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancer
MAN Şendur, S Aksoy, H Yorgun, N Ozdemir, FM Yilmaz, O Yazıcı, ...
Current medical research and opinion 31 (3), 547-556, 2015
132015
Comparison of Improvacuter™ tubes with BD Vacutainer™ tubes for various hormones in the aspects of stability and influence of gel separators
C Zungun, FMÇ Yılmaz, EG Boru, C Topcuoglu
Clinical Chemistry and Laboratory Medicine (CCLM) 53 (2), 231-238, 2015
132015
A comparison of the effects of ketamine and remifentanil on renal functions in coronary artery bypass graft surgery
A Demir, FM Yılmaz, C Ceylan, OG Doluoglu, P Uçar, C Züngün, ...
Renal Failure 37 (5), 819-826, 2015
102015
Evaluation of the analytical performance of Roche immunoturbidimetric immunoglobulin assays and comparing to Dade Behring immunonephelometer.
C Züngün, FM Yılmaz, B Çakır
Journal of Clinical & Experimental Investigations 5 (3), 2014
22014
Akut iskemik inmede yeni bir biyobelirteç olan serum NR2 düzeyinin inmenin şiddeti ve prognozu ile ilişkisi.
E Kasım Ulusoy, E Gürkaş, C Zungun, M İlker Yön, S Sezer, F Ak
Journal of General Medicine/Genel Tıp Dergisi 23 (4), 2013
12013
Serum S100B levels in patients with obstructive sleep apnea syndrome
G Öztürk, Z Giniş, B Arlı, Ş Bilen, G Erden, EK Ulusoy, C Züngün
J Clin Exp Invest www. jceionline. org Vol 3 (3), 2012
12012
Relationship Between Insulin Resistance and Endothelial Dysfunction/Cardiovascular Diseases: The Importance of Method Consideration in Interpretation of Serum Insulin Level
C Züngün, HK Erdemli
EC Cardiology 9, 48-49, 2022
2022
Homocysteine concentrations in heterozygote MTHFR (677C-T) and factor V (1691 GA) mutation-carrying individuals with the history of thromboembolic disease.
HO Doğan, C Zungun, FM Yılmaz, D Kayalp, G Zararsız
2016
Risk Factors of Trastuzumab Induced Cardiotoxicity in Her2-Positive Early Breast Cancer
MA Sendur, S Aksoy, H Yorgun, N Ozdemir, FM Yilmaz, O Yazici, ...
Annals of Oncology 25, iv102, 2014
2014
Comparison of long-term cardiac effects of 9-and 52-week trastuzumab in HER2-positive early breast cancer.
MAN Sendur, S Aksoy, N Özdemir, H Yorgun, FM Yilmaz, O Yazici, ...
Journal of Clinical Oncology 32 (15_suppl), e11582-e11582, 2014
2014
Response to letter to the editor regarding “Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotoxıc effects of organıc solvent exposure” in …
E Tutkun, H Yılmaz, FM Yılmaz, C Züngün
Clinical Toxicology 51 (10), 1245-1245, 2013
2013
Akut iskemik inmede yeni bir biyobelirteç olan serum NR2 düzeyinin inmenin şiddeti ve prognozu ile ilişkisi
EK Ulusoy, E Gürkaş, C Zungun, Mİ Yön, S Sezer, F Ak
Genel Tıp Dergisi 23 (4), 114-119, 2013
2013
Tıkayıcı uyku apne sendromlu hastalarda serum S100B düzeyleri
G Öztürk, Z Giniş, B Arlı, Ş Bilen, G Erden, EK Ulusoy, C Züngün
Journal of Clinical and Experimental Investigations 3 (3), 345-349, 2012
2012
Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer
M ŞENDUR, S AKSOY, N ÖZDEMİR, H YORGUN, F YILMAZ, O YAZICI, ...
Sample Stability in Vitamin D Analysis by Liquid Chromatography Tandem Mass Spectrometry
E Akgöl, S Abuşoğlu, HT Çelik, C Züngün, S Sezer, T Turhan, M Serdar, ...
The system can't perform the operation now. Try again later.
Articles 1–20